Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Research Areas
ELISA
Western Blot
3D Cell Culture
Digital PCR
Quantitative PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
White Papers
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
Antibodies
Antibodies
Mouse Anti-CLDN3 Recombinant Antibody (clone 4B11)
Mouse Anti-CLDN3 Recombinant Antibody (clone 4B11) from Creative Biolabs
Be the first to write a review!
Supplier Page
Supplier Page from
Creative Biolabs for
Mouse Anti-CLDN3 Recombinant Antibody (clone 4B11)
Creative Biolabs'
Mouse Anti-CLDN3 Recombinant Antibody (clone 4B11)
is a Mouse monoclonal antibody. It reacts with Homo Sapiens, and Human. This antibody has been shown to work in applications such as: Immunohistochemistry, and Western Blot.
Product Specs
Company Info
Reviews
Product Specs
Item
Mouse Anti-CLDN3 Recombinant Antibody (clone 4B11)
Company
Creative Biolabs
Price
Supplier Page
View Company Product Page
Catalog Number
MOB-2321z
Applications
WB, IHC
Reactivity
Human
Target
CLDN3
Host
Mouse
Purity
>95% as determined by SDS-PAGE
Clonality
Monoclonal
Clone
4B11
Antibody Type
Primary Antibody
Add to Compare List
Creative Biolabs
Phone
: 1-631-357-2254
1-631-416-1478
Email: info@creative-biolabs.com
Company Profile
Website:
https://www.creativebiolabs.net/
Website:
https://www.creative-biolabs.com/
Reviews
Be the First to Write a Review!
Mouse Anti-CLDN3 Recombinant Antibody (clone 4B11) from Creative Biolabs
Supplier Page
View Company Product Page
Product Specs
Company Info
Reviews
Back To Top